← Evidence map

TrialDiabetes care2008

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.

Vivian A Fonseca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

81 papers cite itlatest 60 shown

2008
…
2011
2012
2013
2014
2015
2016
2017
2018
2019
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 18458145